Quick Answer
HARVARD BIOSCIENCE INC reported Revenue From Contract With Customer Excluding Assessed Tax of $86.55 million for the year ending 2025.
- HARVARD BIOSCIENCE INC showed a decrease of -8.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from HARVARD BIOSCIENCE INC's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), HARVARD BIOSCIENCE INC's Revenue From Contract With Customer Excluding Assessed Tax has declined by 28.3%.
- Historical annual values: Fiscal year 2025: $86.55 million | Fiscal year 2024: $94.14 million | Fiscal year 2023: $112.25 million | Fiscal year 2022: $113.34 million | Fiscal year 2021: $118.90 million | Fiscal year 2020: $102.10 million | Fiscal year 2019: $116.18 million | Fiscal year 2018: $120.77 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: